| Primary |
| Product Used For Unknown Indication |
19.3% |
| Breast Cancer |
13.2% |
| Colon Cancer |
11.5% |
| Breast Cancer Metastatic |
8.7% |
| Colorectal Cancer |
7.4% |
| Drug Use For Unknown Indication |
6.5% |
| Gastric Cancer |
5.5% |
| Rectal Cancer |
5.4% |
| Colorectal Cancer Metastatic |
3.7% |
| Colon Cancer Metastatic |
3.3% |
| Hypertension |
2.5% |
| Rectal Cancer Metastatic |
2.1% |
| Pain |
1.8% |
| Large Intestine Carcinoma |
1.7% |
| Pancreatic Carcinoma |
1.6% |
| Metastatic Gastric Cancer |
1.4% |
| Neoplasm Malignant |
1.3% |
| Prophylaxis |
1.1% |
| Colon Cancer Recurrent |
1.1% |
| Oesophageal Carcinoma |
0.9% |
|
| Death |
46.9% |
| Disease Progression |
10.8% |
| Vomiting |
7.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
5.2% |
| Diarrhoea |
4.6% |
| Malignant Neoplasm Progression |
4.5% |
| Weight Decreased |
2.7% |
| Stomatitis |
2.1% |
| Thrombocytopenia |
1.8% |
| Nausea |
1.6% |
| White Blood Cell Count Decreased |
1.5% |
| Pyrexia |
1.5% |
| Sepsis |
1.3% |
| Neoplasm Malignant |
1.3% |
| Interstitial Lung Disease |
1.2% |
| Mucosal Inflammation |
1.2% |
| Skin Exfoliation |
1.1% |
| Metastases To Liver |
1.1% |
| Renal Failure |
1.1% |
| Intestinal Obstruction |
1.0% |
|
| Secondary |
| Breast Cancer |
21.4% |
| Product Used For Unknown Indication |
11.7% |
| Breast Cancer Metastatic |
9.4% |
| Colon Cancer |
6.5% |
| Drug Use For Unknown Indication |
6.4% |
| Gastrooesophageal Cancer |
6.0% |
| Colon Cancer Metastatic |
5.0% |
| Rectal Cancer |
4.6% |
| Gastric Cancer |
4.2% |
| Prophylaxis |
4.0% |
| Colorectal Cancer Metastatic |
3.9% |
| Colorectal Cancer |
3.2% |
| Rectal Cancer Metastatic |
2.7% |
| Hypertension |
2.4% |
| Pain |
1.7% |
| Cancer Pain |
1.7% |
| Metastatic Gastric Cancer |
1.7% |
| Large Intestine Carcinoma |
1.4% |
| Metastases To Bone |
1.1% |
| Pancreatic Carcinoma |
1.1% |
|
| Vomiting |
14.0% |
| Death |
13.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
12.1% |
| Diarrhoea |
7.7% |
| Disease Progression |
7.1% |
| Pulmonary Embolism |
5.1% |
| Stomatitis |
5.1% |
| Weight Decreased |
4.8% |
| Rash |
4.1% |
| White Blood Cell Count Decreased |
3.8% |
| Pyrexia |
3.6% |
| Nausea |
3.5% |
| Thrombocytopenia |
2.5% |
| Renal Failure Acute |
2.4% |
| Sepsis |
2.3% |
| Malignant Neoplasm Progression |
2.1% |
| Neuropathy Peripheral |
1.9% |
| Neutropenia |
1.8% |
| Decreased Appetite |
1.6% |
| Fatigue |
1.6% |
|
| Concomitant |
| Breast Cancer |
32.5% |
| Metastases To Bone |
13.8% |
| Breast Cancer Metastatic |
12.6% |
| Drug Use For Unknown Indication |
6.1% |
| Premedication |
5.5% |
| Product Used For Unknown Indication |
4.8% |
| Colon Cancer |
4.3% |
| Pain |
3.2% |
| Prophylaxis |
2.5% |
| Hypertension |
2.2% |
| Colorectal Cancer Metastatic |
1.6% |
| Breast Cancer Recurrent |
1.6% |
| Depression |
1.4% |
| Colorectal Cancer |
1.3% |
| Chemotherapy |
1.2% |
| Nausea |
1.2% |
| Cancer Pain |
1.1% |
| Diabetes Mellitus |
1.1% |
| Colon Cancer Metastatic |
1.1% |
| Prophylaxis Of Nausea And Vomiting |
1.0% |
|
| Vomiting |
13.8% |
| Tooth Extraction |
9.7% |
| Diarrhoea |
9.1% |
| Weight Decreased |
8.4% |
| Nausea |
6.8% |
| Death |
6.5% |
| Rash |
5.7% |
| Pyrexia |
4.8% |
| Osteonecrosis |
4.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
4.2% |
| Fatigue |
3.8% |
| Toothache |
3.5% |
| Disease Progression |
3.1% |
| Vision Blurred |
3.0% |
| Stomatitis |
2.4% |
| White Blood Cell Count Decreased |
2.3% |
| Wound Dehiscence |
2.3% |
| Neoplasm Malignant |
2.2% |
| Wound Debridement |
2.2% |
| Malaise |
1.9% |
|
| Interacting |
| Colon Cancer Metastatic |
13.8% |
| Hypertension |
10.7% |
| Large Intestine Carcinoma |
10.2% |
| Product Used For Unknown Indication |
9.2% |
| Diabetes Mellitus |
7.1% |
| Atrial Fibrillation |
6.1% |
| Drug Use For Unknown Indication |
6.1% |
| Breast Cancer |
4.6% |
| Anaemia |
3.6% |
| Analgesic Therapy |
3.6% |
| Benign Prostatic Hyperplasia |
3.6% |
| Constipation |
3.6% |
| Colorectal Cancer Metastatic |
3.1% |
| Epilepsy |
2.6% |
| Mitral Valve Incompetence |
2.6% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
| Breast Cancer Metastatic |
2.0% |
| Colon Cancer Stage Iv |
2.0% |
| Colon Cancer |
1.5% |
| Gastric Cancer |
1.5% |
|
| White Blood Cell Count Decreased |
11.6% |
| Epilepsy |
9.3% |
| Prothrombin Time Prolonged |
9.3% |
| Faeces Discoloured |
7.0% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
7.0% |
| Subdural Haematoma |
7.0% |
| Toxicity To Various Agents |
7.0% |
| Cough |
4.7% |
| Drug Interaction |
4.7% |
| Pyrexia |
4.7% |
| Rash |
4.7% |
| Stomatitis |
4.7% |
| Bone Marrow Failure |
2.3% |
| Gastrointestinal Haemorrhage |
2.3% |
| Hallucination, Visual |
2.3% |
| International Normalised Ratio Fluctuation |
2.3% |
| International Normalised Ratio Increased |
2.3% |
| Mononeuropathy Multiplex |
2.3% |
| Myocardial Infarction |
2.3% |
| Syncope |
2.3% |
|
